Vaccine News for Parents: Measles Deaths, HPV Gaps, and 2026–27 Season Reviews
US measles cases have climbed to 3,134 with a second infant death confirmed in Lancaster County, Pennsylvania, while an independent group has released a formal review of 2026–27 respiratory vaccines for flu, COVID-19, and RSV. Here is what parents need to know this week.
By TinyDose AdminAuthor
Two significant updates arrived this week. The US measles case count crossed another threshold, and an independent group published a formal review of the respiratory vaccines recommended for the 2026–27 season. Neither item changes the childhood schedule, but both are worth understanding.
A Second Infant Death in Lancaster County
The Lancaster County coroner confirmed a second infant death caused by measles, according to CIDRAP. US cases now stand at 3,134, up from the roughly 3,000 reported here three days ago. Pennsylvania's outbreak continues to expand.
This news arrives alongside a painful public dispute. A CIDRAP op-ed published this week pushed back on the suggestion, attributed to a federal official, that the first Lancaster County newborn death may have been incidental rather than caused by measles. The family, CIDRAP noted, "deserve better" than that framing. The piece argued that applying the "died with, not from" lens, a framework that had real relevance during the COVID-19 pandemic, is the wrong one for measles, where the causal relationship is well established.
For parents of young children who are not yet fully vaccinated, the measles-mumps-rubella (MMR) vaccine remains the clearest protection available. The first dose is typically given at 12 to 15 months. If your child is behind on MMR, check with your paediatrician about catching up.
The 2026–27 Respiratory Vaccine Review Is Out
On September 2, 2026, the Vaccine Integrity Project (VIP), working with the American Medical Association and other leading US medical organisations, released a review of the evidence on flu, COVID-19, and RSV vaccines for the upcoming respiratory season. The Gerontological Society of America, which focuses on older adults, has signalled its support for the findings, according to News-Medical.net.
Researchers on this project say they "systematically reviewed the newest scientific evidence" on the effectiveness and safety of these three vaccines, per the CIDRAP commentary associated with the effort. The review is notable partly because it was produced outside the federal advisory process, which has faced what the American Academy of Pediatrics describes as "unprecedented criticism" this year.
This is not a new schedule, and it does not change what children are recommended to receive. RSV protection for infants (through nirsevimab or maternal vaccination during pregnancy) and flu shots for children six months and older remain on the existing schedule. If you have questions about what your baby or toddler needs this respiratory season, check with your paediatrician.
HPV Vaccine Uptake Among US Teens Has Stalled
Human papillomavirus (HPV) vaccine uptake among US adolescents has not increased in four years, according to CIDRAP. A slight dip was also noted in the share of teens receiving Tdap (the combined tetanus, diphtheria, and pertussis booster) and meningococcal vaccines.
This matters for parents of children approaching the recommended age range. The HPV vaccine is typically offered around 11 to 12 years, well before the toddler years, but many paediatricians begin the conversation earlier. If your child is approaching school age, it's a reasonable question to raise at your next well-child visit. The Tdap booster is also given in adolescence and provides continued protection against whooping cough (pertussis), which can be serious for younger siblings and unvaccinated infants in the household.
Thailand Eliminates Rubella; India Works to Reach Missed Children
Two pieces of good news from the region this week. The World Health Organization announced that Thailand has been verified for eliminating rubella as a public health problem. Rubella is one component of the MMR vaccine, and its elimination is a meaningful milestone.
In India, WHO South-East Asia reporting noted ongoing work to reach children who are being missed by urban immunisation programs, including through a tracking initiative called TrackVac that aims to find and vaccinate the most hard-to-reach infants. Measles-rubella vaccination drives are also under way in Andhra Pradesh, according to the WHO South-East Asia news room.
For parents in India and the Philippines, these stories are a reminder that immunisation coverage varies significantly by area. Checking whether your child is up to date on the local schedule, including measles-rubella, is always worthwhile, especially if you've recently moved or missed a health visit.
Vaccine Policy Uncertainty Is Real, and Not Going Away Soon
A CIDRAP analysis this week put plainly what many parents may be sensing: there are now three things the CDC no longer reliably provides, including clear information on what vaccines are recommended, whether walk-in access is available, and what disease activity looks like nationally. The advisory committee process (ACIP) is facing scrutiny, and a AAP podcast featuring Dr. Sean O'Leary, chair of the AAP Committee on Infectious Diseases, addressed directly why childhood vaccine recommendations are facing what he called unprecedented criticism.
This creates real confusion for parents trying to do the right thing. The most stable anchor available right now is your child's paediatrician, who has access to current guidance and knows your child's history.
What This Means for You
Nothing in this week's news requires you to act immediately or change any scheduled appointment. The key updates: measles cases in the US continue to rise (now 3,134), a second infant in Pennsylvania has died, and an independent vaccine review for the 2026–27 respiratory season is now available to clinicians. HPV and Tdap uptake among US teens is flat or slightly down, which is worth raising at the next adolescent well-child visit. And if you're in India or the Philippines, WHO-supported catch-up efforts are expanding, so the opportunity to close any gaps in your child's schedule is real. Check with your paediatrician if you're unsure where your child stands.
Common questions
How many measles cases have been reported in the US in 2026?
- As of the most recent update reported by CIDRAP, the US measles case total stands at 3,134. The outbreak in Lancaster County, Pennsylvania continues to expand.
What happened with the infant deaths in Lancaster County?
- According to CIDRAP, the Lancaster County coroner confirmed that a second infant in the county died as a result of measles. A CIDRAP op-ed also addressed public statements suggesting the first infant's death may have been incidental, arguing that framing is not appropriate for measles.
What did the Vaccine Integrity Project review cover?
- The Vaccine Integrity Project, working with the American Medical Association and other US medical organisations, released a review on September 2, 2026, examining the evidence on flu, COVID-19, and RSV vaccines for the 2026–27 respiratory season. According to CIDRAP, researchers systematically reviewed effectiveness and safety data. This is a review for clinicians, not a change to the childhood vaccine schedule.
Why has HPV vaccine uptake stalled in US teens?
- According to CIDRAP, HPV (human papillomavirus) vaccine uptake among US adolescents has not increased in four years. The report also noted a slight dip in the share of teens receiving Tdap and meningococcal vaccines. The sources reviewed do not explain the specific reasons for the stall.
What is happening with measles and rubella vaccination in India and the Philippines?
- WHO South-East Asia reporting noted that measles-rubella vaccination drives are under way in Andhra Pradesh, India, and that a program called TrackVac is working to find and vaccinate hard-to-reach children in India's expanding cities. Thailand was separately verified by WHO for eliminating rubella as a public health problem. Parents in India and the Philippines are encouraged to check with their paediatrician about their child's current immunisation status.
- Lancaster County coroner says measles caused second infant death as US cases soar past 3,100
- CIDRAP Op-Ed: 'Died with, not from' was a real COVID problem. It's the wrong framework for measles.
- Vaccine Integrity Project, American Medical Association review COVID, flu, and RSV vaccines
- HPV vaccine uptake in US teens hasn't increased in 4 years
- Vaccine recommendations and access, plus measles deaths: 3 questions, zero consensus
- WHO South-East Asia Region News Room
This information is provided by TinyDose for general understanding only and is not medical advice. Vaccine names, ages and doses can vary by country, brand and individual circumstances. Always follow the guidance of your pediatrician or local health authority for your child’s vaccination schedule.
© 2026 Alpstack · TinyDose
Keep reading
NHS vaccine schedule changes 2026: what's new and is your Red Book still right?
The NHS overhauled the childhood immunisation schedule for 2026: MMRV replaces MMR, a new 18-month appointment appears, and second doses move earlier. Here is what changed, who is affected by birth date, and why your printed Red Book may now be wrong.
Missed your baby's vaccine? Catch-up schedule and what to do next
A missed dose almost never means starting the series again. Here is the age-wise catch-up guide, the handful of vaccines that have a real deadline, and the exact steps to take this week.
CDC vs AAP 2026 Vaccine Schedule: Which Should You Follow?
In a rare split, the CDC and the American Academy of Pediatrics have released differing childhood immunization schedules for 2026. Here is a strictly neutral look at what changed, what stayed the same, and how to navigate the new guidance.